Select a medication above to begin.
rhizoma zingiberi
ginger (Zingiber officinale)
Entire Monograph
Reported Uses
- NOTE: see Herb & Supplement Effectiveness Rating Definitions table
- allergic rhinitis [Insufficient Evidence]
- anorexia, cancer-related [Insufficient Evidence]
- ARDS [Insufficient Evidence]
- asthma [Insufficient Evidence]
- back pain [Insufficient Evidence]
- burns [Insufficient Evidence]
- colic [Insufficient Evidence]
- constipation [Insufficient Evidence]
- COPD [Insufficient Evidence]
- COVID-19 [Insufficient Evidence]
- diabetes mellitus [Insufficient Evidence]
- diarrhea [Insufficient Evidence]
- dysmenorrhea [Possibly Effective]
- dyspepsia [Insufficient Evidence]
- erectile dysfxn [Insufficient Evidence]
- exercise-induced muscle soreness [Possibly Ineffective]
- hangover [Insufficient Evidence]
- hepatotoxicity, toxin-induced [Insufficient Evidence]
- HTN [Insufficient Evidence]
- hyperlipidemia [Insufficient Evidence]
- hypothyroidism [Insufficient Evidence]
- IBS [Insufficient Evidence]
- insect bite [Insufficient Evidence]
- joint pain [Insufficient Evidence]
- menopausal sx [Insufficient Evidence]
- menorrhagia [Insufficient Evidence]
- migraine, acute [Insufficient Evidence]
- motion sickness [Possibly Ineffective]
- multiple sclerosis [Insufficient Evidence]
- nausea/vomiting, antiretroviral-related [Insufficient Evidence]
- nausea/vomiting, chemo-related [Possibly Ineffective]
- nausea/vomiting, gastroenteritis-related [Insufficient Evidence]
- nausea/vomiting, intraop [Insufficient Evidence]
- nausea/vomiting, postop [Insufficient Evidence]
- nausea/vomiting, pregnancy-related [Possibly Effective]
- nausea/vomiting, radiation-related [Insufficient Evidence]
- nonalcoholic fatty liver dz [Insufficient Evidence]
- obesity [Insufficient Evidence]
- osteoarthritis [Possibly Effective]
- parturition [Insufficient Evidence]
- polycystic ovary syndrome [Insufficient Evidence]
- postop recovery [Insufficient Evidence]
- postpartum complications [Insufficient Evidence]
- rheumatoid arthritis [Insufficient Evidence]
- smoking cessation [Insufficient Evidence]
- swallowing dysfxn [Insufficient Evidence]
- traumatic brain injury [Insufficient Evidence]
- ulcerative colitis [Insufficient Evidence]
- URI [Insufficient Evidence]
- vertigo [Insufficient Evidence]
- xerostomia [Insufficient Evidence]
Reported Doses
Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely
Special Note, COVID-19
- [no scientific data for COVID-19]
- Info: see Herb & Supplement Remedy Use in COVID-19 Resources
Effectiveness Ratings
- [see Herb & Supplement Effectiveness Rating Definitions table]
allergic rhinitis
- [Insufficient Evidence]
- Dose: 500 mg PO qd
anorexia, cancer-related
- [Insufficient Evidence]
- Dose: 1650 mg PO qd
ARDS
- [Insufficient Evidence]
- Dose: 40 mg NG tid
COPD
- [Insufficient Evidence]
- Dose: 10 mL (100 mg) syrup PO tid; Info: given in 100 mL warm water
COVID-19
- [Insufficient Evidence]
- Dose: 1-1.5 g PO bid
diabetes mellitus
- [Insufficient Evidence]
- Dose: 1.2-3 g/day PO divided qd-tid
dysmenorrhea, adult pts
- [Possibly Effective]
- Dose: 200-250 mg PO qid; Alt: 500 mg PO qd-tid; Start: up to 2 days before menstrual cycle
dysmenorrhea, peds pts
- [Possibly Effective]
- Dose: 250 mg PO tid in pts 15-18; Start: 1 day before menstrual cycle
dyspepsia
- [Insufficient Evidence]
- Dose: 1.2 g PO qd; Info: given 60min before meal
erectile dysfxn
- [Insufficient Evidence]
- Dose: 250 mg PO bid
hangover
- [Insufficient Evidence]
- Dose: 6 g PO x1; Info: given 5h prior to alcohol consumption; may repeat 6 g PO bid x2 days
hepatotoxicity, toxin-induced
- [Insufficient Evidence]
- Dose: 500 mg PO qd
hyperlipidemia
- [Insufficient Evidence]
- Dose: 1 g PO tid; Alt: 200-3000 mg PO qd
hypothyroidism
- [Insufficient Evidence]
- Dose: 500 mg PO bid
IBS
- [Insufficient Evidence]
- Dose: 150 mg PO tid
joint pain
- [Insufficient Evidence]
- Dose: 50 mg/day PO divided tid
menorrhagia
- [Insufficient Evidence]
- Dose: 250 mg PO tid x4 days; Start: 1 day before menstrual cycle
migraine, acute
- [Insufficient Evidence]
- Dose: 250-400 mg PO x1; Start: at onset of headache
multiple sclerosis
- [Insufficient Evidence]
- Dose: 500 mg PO tid
nausea/vomiting, antiretroviral-related
- [Insufficient Evidence]
- Dose: 500 mg PO bid; Info: given 30min before antiretroviral dose
nausea/vomiting, gastroenteritis-related, peds pts
- [Insufficient Evidence]
- Dose: 20 gtt (10 mg) ginger liquid PO x1, then cont. q8h until vomiting cessation; Info: for pts 1-10 yo
nausea/vomiting, intraop
- [Insufficient Evidence]
- Dose: 1 g PO x1 given 30min before anesthesia
nausea/vomiting, postop
- [Insufficient Evidence]
- Dose: 1-2 g PO x1 given 30-60min before anesthesia, then 1 g PO x1 given 2h after surgery; Alt: apply 5% ginger essential oil to wrists for inhaled aromatherapy before surgery; ginger oil diffused for inhaled aromatherapy x3 postop
nausea/vomiting, pregnancy-related
- [Possibly Effective]
- Dose: 500-2500 mg/day PO divided bid-qid; Alt: 250 mg PO qid
nonalcoholic fatty liver dz
- [Insufficient Evidence]
- Dose: 1500 mg PO qd; Alt: 1000 mg PO bid
osteoarthritis
- [Possibly Effective (PO route)]
- Dose: 500-1000 mg PO qd; Alt: 170 mg PO tid; 340 mg PO qd; 30 mg PO qd
- [Possibly Effective (topical route)]
- Dose: apply 1 g (4-5% gel) topically tid-qid; Alt: apply ointment topically bid
polycystic ovary syndrome
- [Insufficient Evidence]
- Dose: 500 mg PO tid
postop recovery
- [Insufficient Evidence]
- Dose: 500 mg PO bid
postpartum complications
- [Insufficient Evidence]
- Dose: 500 mg PO x1 given 8h postpartum, then 250 mg PO q8h x1 day
rheumatoid arthritis
- [Insufficient Evidence]
- Dose: 1500 mg PO qd
smoking cessation
- [Insufficient Evidence]
- Dose: 25 mg PO qd
swallowing dysfxn
- [Insufficient Evidence]
- Dose: apply spray topically to oropharynx qd
traumatic brain injury
- [Insufficient Evidence]
- Dose: 36 mg PO tid; Info: used w/ boswellia
ulcerative colitis
- [Insufficient Evidence]
- Dose: 1000 mg PO bid
vertigo
- [Insufficient Evidence]
- Dose: 1 g PO x1
xerostomia
- [Insufficient Evidence]
- Dose: 20 mL (25% mouthwash) swish/spit tid
Copyright © 2024. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.